Table 2.
Potential systemic risk factors for pseudoexfoliation by univariate analysis
| Mean±SD or total number (%) | P | ||
|---|---|---|---|
| Pseudoexfoliation (n=49) | Control (n=61) | ||
| Age | 78.4±9.0 | 71.0±10.3 | <0.001 |
| Gender | 21 male (42.9) | 25 male (41.0) | 0.42 |
| Diabetes mellitus | 11 (22.4) | 18 (29.5) | 0.20 |
| Systemic hypertension | 18 (36.7) | 29 (47.5) | 0.13 |
| Coronary artery disease | 15 (30.6) | 13 (21.3) | 0.13 |
| Morbid obesity | 2 (4.1) | 2 (3.3) | 0.413 |
| Asthma or atopy | 7 (14.6) | 8 (13.1) | 0.41 |
| Sensorineural hearing loss | 14 (28.6) | 12 (19.7) | 0.14 |
| Erectile dysfunction | 12 (54.5) | 3 (17.6) | 0.0069 |
| Oral alpha agonist intake | 6 (31.2) | 8 (32.0) | 0.45 |
SD: Standard deviation